This is the authors' abstract. We don't add key points for this paper.
Rhinosinusitis is a common condition, affecting a large number of patients. In the vast majority of cases, the origin is viral. Results of the studies included in this article indicate that only 0.5-2% of all cases have bacterial etiology. Despite these facts, antibiotics are still widely prescribed for this condition. The aim of this study is to examine antibiotic overuse in rhinosinusitis and potential consequences of this practice. This review paper was based on resources available in the PubMed database; articles were identified using the following keywords: “rhinosinusitis AND antibiotic resistance”, “rhinosinusitis AND antibiotic overuse” and “acute rhinosinusitis.”. All included articles were published between 2020-2026. Results indicate that overuse of antibiotics in rhinosinusitis is a common practice in many countries. Increasing antibiotic resistance, along with the spread of multi-drug resistant microbes is one of the major consequences. Recent findings highlight the role of the respiratory microbiota and indicate that antibiotic therapy induces long-term changes in the nasal microbiome. Research shows that there are no significant differences in clinical effectiveness between amoxicillin and amoxicillin-clavulanate. In conclusion, antibiotic overuse in rhinosinusitis is a prevalent trend and it poses an important problem of public health. Further research is needed to better understand this issue. The implementation of educational programs and development of clear treatment guidelines may help address this problem.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gawlak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: